$Kiora Pharmaceuticals(KPRX.US)$Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study Thu, Apr 11, 2024 Encinitas, California--(Newsfile Corp. - April 11, 2024) -Kiora Pharmaceuticals, Inc.(NASDAQ: KPRX) has received grant funding from the Choroideremia Research Foundation (CRF) in support of validating functional vision assessments for pat...
$Kiora Pharmaceuticals(KPRX.US)$Kiora Announces Publication of Phase 1 Study Demonstrating Safety, Tolerability and Anti-Inflammatory Activity of KIO-101 in the Treatment of Inflammation of the Eye newsfile· 6 mins ago
Kiora Pharmaceuticals股票讨论区
Update
Thu, Apr 11, 2024
Encinitas, California--(Newsfile Corp. - April 11, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) has received grant funding from the Choroideremia Research Foundation (CRF) in support of validating functional vision assessments for pat...
Update
newsfile· 6 mins ago
暂无评论